Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 130,758 | 131,612 | 115,221 | 106,554 | 121,007 |
| Cost of Goods | 10,742 | 3,688 | 2,526 | 2,185 | 2,508 |
| Gross Profit | 120,016 | 127,924 | 112,695 | 104,369 | 118,499 |
| Operating Expenses | 165,415 | 143,913 | 156,930 | 171,326 | 186,169 |
| Operating Income | -44,657 | -15,301 | -43,709 | -66,772 | -67,162 |
| Other Income | 1,752 | 512 | 311 | 345 | 819 |
| Pre-tax Income | -42,905 | -14,789 | -43,398 | -66,427 | -66,343 |
| Income Tax | 189 | -332 | 473 | 21 | 417 |
| Net Income Continuous | -43,094 | -14,457 | -43,871 | -66,448 | -66,760 |
| Net Income | $-43,094 | $-14,457 | $-43,871 | $-66,448 | $-66,760 |
| EPS Basic Total Ops | -0.27 | -0.09 | -0.27 | -0.42 | -0.41 |
| EPS Basic Continuous Ops | -0.27 | -0.09 | -0.27 | -0.42 | -0.42 |
| EPS Diluted Total Ops | -0.27 | -0.09 | -0.27 | -0.42 | -0.41 |
| EPS Diluted Continuous Ops | -0.27 | -0.09 | -0.27 | -0.42 | -0.42 |
| EBITDA(a) | $-43,484 | $-13,726 | $-42,293 | $-65,188 | $-65,675 |